Europe Neuroendocrine Tumors Market to 2032
Overview
The Europe Neuroendocrine Tumors Market is expected to reach a 1,702.19 USD Million by 2032 and is projected to grow at a CAGR of 16.50% from 2025 to 2032.
Revenue, 2024 (USD Million)
747.30
Forecast, 2032 (USD Million)
1,702.19
CAGR, 2024 - 2032
16.50%
Report Coverage
Europe
Europe Neuroendocrine Tumors Market 2018-2032 USD Million
Europe Neuroendocrine Tumors Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 747.30 USD Million
- Projected Market Size (2032): 1,702.19 USD Million
- CAGR (2025-2032): 16.50%
Key Findings of Europe Neuroendocrine Tumors Market
- The Europe Neuroendocrine Tumors Market was valued at 747.30 USD Million in 2024.
- The Europe Neuroendocrine Tumors Market is likely to grow at a CAGR of 16.50% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Non-Funtional NET in Classification Segment accounted for the largest share of the market with a revenue of 519.37 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 26.42% during the forecast period from 2024 to 2032.
Europe Neuroendocrine Tumors Market Scope
Europe Neuroendocrine Tumors Market Segmentation & Scope
Classification
- Funtional NET
- Non-Funtional NET
Site
- Pancreas
- Lungs
- Gastrointestinal Tract (GI)
Grade
- Grade 1 (Low-Grade Tumor)
- Grade 3 (High-Grade Tumor)
- Grade 2 (Intermediate-Grade Tumor)
Type
- Treatment
- Diagnosis
Route of Administration
- Parenteral
- Oral
End User
- Others
- Home Healthcare
- Radiation Centers
- Speciality Clinics
- Hospitals
Distribution Channel
- Others
- Online Pharmacy
- Retail Sales
- Hospital Pharmacy
- Direct Tender
Europe Neuroendocrine Tumors Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 747.30 USD Million |
| Market Value in 2032 | 1,702.19 USD Million |
| CAGR (2025-2032) | 16.50% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Classification,Site,Grade ,Type,Route of Administration,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 747.30 USD Million in 2024
- Key Country: Germany, leading in terms of revenue with value of 181.08 USD Million in 2024.
Segments and Scope
-
Europe Neuroendocrine Tumors Market to 2032, By Classification
- Non-Funtional NET is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 519.37 USD Million in the year 2024.
- Non-Funtional NET is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 16.92 % in forecast period 2025-2032.
-
Europe Neuroendocrine Tumors Market to 2032, By Site
- Gastrointestinal Tract (GI) is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 387.58 USD Million in the year 2024.
- Gastrointestinal Tract (GI) is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 17.36 % in forecast period 2025-2032.
-
Europe Neuroendocrine Tumors Market to 2032, By Grade
- Grade 2 (Intermediate-Grade Tumor) is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 385.51 USD Million in the year 2024.
- Grade 2 (Intermediate-Grade Tumor) is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 16.89 % in forecast period 2025-2032.
-
Europe Neuroendocrine Tumors Market to 2032, By Type
- Diagnosis is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 488.04 USD Million in the year 2024.
- Treatment is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 12.25 % in forecast period 2025-2032.
-
Europe Neuroendocrine Tumors Market to 2032, By Route of Administration
- Oral is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 41.79 USD Million in the year 2024.
- Oral is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 26.42 % in forecast period 2025-2032.
-
Europe Neuroendocrine Tumors Market to 2032, By End User
- Hospitals is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 296.64 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 15.52 % in forecast period 2025-2032.
-
Europe Neuroendocrine Tumors Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Neuroendocrine Tumors Market to 2032 with a revenue of 274.04 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Neuroendocrine Tumors Market to 2032 with a Growth rate of 17.78 % in forecast period 2025-2032.
Europe Neuroendocrine Tumors Market Company Share Analysis
| Company Name |
|
||
| Mylan N.V. | |||
| Novartis AG | |||
| Lupin | |||
| Lilly | |||
| Thermo Fisher Scientific Inc. | |||
Europe Neuroendocrine Tumors Market Geographical Sales Distribution, 2018-2032 USD Million
Europe Neuroendocrine Tumors Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Neuroendocrine Tumors Market is segmented based on Segmentation Classification,Site,Grade ,Type,Route of Administration,End User,Distribution Channel.
Europe Neuroendocrine Tumors Market was valued at USD 747.30(Revenue in USD Million) in 2020.
Europe Neuroendocrine Tumors Market is projected to grow at a CAGR of 16.50% during the forecast period of 2024 to 2032.
The Non-Funtional NET segment is expected to dominate the Europe Neuroendocrine Tumors Market, holding a largest market share of 519.37 USD Million in 2024
Europe Neuroendocrine Tumors Market Scope
Europe Neuroendocrine Tumors Market Segmentation & Scope
Classification
- Funtional NET
- Non-Funtional NET
Site
- Pancreas
- Lungs
- Gastrointestinal Tract (GI)
Grade
- Grade 1 (Low-Grade Tumor)
- Grade 3 (High-Grade Tumor)
- Grade 2 (Intermediate-Grade Tumor)
Type
- Treatment
- Diagnosis
Route of Administration
- Parenteral
- Oral
End User
- Others
- Home Healthcare
- Radiation Centers
- Speciality Clinics
- Hospitals
Distribution Channel
- Others
- Online Pharmacy
- Retail Sales
- Hospital Pharmacy
- Direct Tender
Frequently Asked Questions
The Europe Neuroendocrine Tumors Market is segmented based on Segmentation Classification,Site,Grade ,Type,Route of Administration,End User,Distribution Channel.
Europe Neuroendocrine Tumors Market was valued at USD 747.30(Revenue in USD Million) in 2020.
Europe Neuroendocrine Tumors Market is projected to grow at a CAGR of 16.50% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Neuroendocrine Tumors Market for final year is USD 1,702.19 (USD Million).
Europe Neuroendocrine Tumors Market Company Profiling
Frequently Asked Questions
The Europe Neuroendocrine Tumors Market is segmented based on Segmentation Classification,Site,Grade ,Type,Route of Administration,End User,Distribution Channel.
Europe Neuroendocrine Tumors Market was valued at USD 747.30(Revenue in USD Million) in 2020.
Europe Neuroendocrine Tumors Market is projected to grow at a CAGR of 16.50% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Neuroendocrine Tumors Market for final year is USD 1,702.19 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.